SMART Medical Systems Launches its G-EYE® 760R Colonoscope in the European Endoscopy Market Through FUJIFILM Europe

Under Strategic Distribution Partnership With FUJIFILM Corporation, to Provide Synergetic Colonoscopy Solution in Fight Against Colon Cancer

SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, announced a strategic distribution partnership empowering Fujifilm to commercialize SMART’s G-EYE® endoscope in Europe.

The G-EYE® endoscope is a conventional colonoscope onto which SMART’s G-EYE® balloon is integrated. Withdrawal of the G-EYE® endoscope in the colon with the balloon moderately inflated centralizes the image in the colon lumen and flattens colonic folds. This effect is designed to provide enhanced visualization of the colon and was proven in numerous clinical studies to enable a substantial increase in the detection of cancerous polyps which are the precursors of colon cancer (e.g., GIE Vol.89, No.3, 2019, p545-553).

The flagship product to be commercialized under the new partnership is the G-EYE® 760R colonoscope, integrating the G-EYE® Balloon Technology with Fujifilm’s ELUXEO system, and yielding a highly optimized colonoscopy system for screening, diagnostic and therapeutic colonoscopy.

“Our new partnership with Fujifilm is a solid and strategic relation substantiating our common efforts of making the G-EYE® balloon endoscope available to more hospitals and practitioners, starting in Europe,” said Gadi Terliuc, SMART’s CEO. “We are excited to make the product available by Fujifilm and gain market share with a clear focus on colonoscopy.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”